DK1196170T3 - Anvendelse af en makrolidforbindelse til fremstilling af et medikament til behandling af hjerneskade forårsaget af iskæmi eller blödning - Google Patents
Anvendelse af en makrolidforbindelse til fremstilling af et medikament til behandling af hjerneskade forårsaget af iskæmi eller blödningInfo
- Publication number
- DK1196170T3 DK1196170T3 DK00946165T DK00946165T DK1196170T3 DK 1196170 T3 DK1196170 T3 DK 1196170T3 DK 00946165 T DK00946165 T DK 00946165T DK 00946165 T DK00946165 T DK 00946165T DK 1196170 T3 DK1196170 T3 DK 1196170T3
- Authority
- DK
- Denmark
- Prior art keywords
- ischemia
- bleeding
- medicament
- manufacture
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9917158.9A GB9917158D0 (en) | 1999-07-21 | 1999-07-21 | New use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1196170T3 true DK1196170T3 (da) | 2004-08-30 |
Family
ID=10857695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00946165T DK1196170T3 (da) | 1999-07-21 | 2000-07-19 | Anvendelse af en makrolidforbindelse til fremstilling af et medikament til behandling af hjerneskade forårsaget af iskæmi eller blödning |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20060287353A1 (ja) |
| EP (1) | EP1196170B1 (ja) |
| JP (1) | JP2003504396A (ja) |
| KR (1) | KR100508623B1 (ja) |
| CN (1) | CN1200710C (ja) |
| AT (1) | ATE270888T1 (ja) |
| AU (1) | AU6003900A (ja) |
| CA (1) | CA2379140A1 (ja) |
| DE (1) | DE60012183T2 (ja) |
| DK (1) | DK1196170T3 (ja) |
| ES (1) | ES2220492T3 (ja) |
| GB (1) | GB9917158D0 (ja) |
| HK (1) | HK1047704B (ja) |
| PT (1) | PT1196170E (ja) |
| WO (1) | WO2001005385A2 (ja) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR035411A1 (es) * | 2000-12-29 | 2004-05-26 | Fujisawa Pharmaceutical Co | Uso de un derivado de tacrolimus para fabricar un agente neurotrofico, composiciones y articulos de fabricacion o kits que lo comprenden, metodo para fabricar un agente que lo comprende y tejidos e injertos con una celula nerviosa tratada con este compuesto |
| AU2003901023A0 (en) * | 2003-03-04 | 2003-03-20 | Fujisawa Pharmaceutical Co., Ltd. | New use |
| CA2554045A1 (en) * | 2004-01-20 | 2005-07-28 | Astellas Pharma Inc. | Method for treating erectile dysfunction |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4894366A (en) * | 1984-12-03 | 1990-01-16 | Fujisawa Pharmaceutical Company, Ltd. | Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
| GB8728820D0 (en) * | 1987-12-09 | 1988-01-27 | Fisons Plc | Compounds |
| GR1001225B (el) * | 1989-09-14 | 1993-06-30 | Fisons Plc | Νέαι μακροκυκλικαί ενώσεις και νέα μέ?οδος χρήσεως τους. |
| GB9202196D0 (en) * | 1992-02-01 | 1992-03-18 | Fisons Plc | Method of treatment |
| GB9218027D0 (en) * | 1992-08-25 | 1992-10-14 | Fisons Plc | Novel method of treatment |
| GB9227055D0 (en) * | 1992-12-29 | 1993-02-24 | Fujisawa Pharmaceutical Co | New use |
-
1999
- 1999-07-21 GB GBGB9917158.9A patent/GB9917158D0/en not_active Ceased
-
2000
- 2000-07-19 EP EP00946165A patent/EP1196170B1/en not_active Expired - Lifetime
- 2000-07-19 DK DK00946165T patent/DK1196170T3/da active
- 2000-07-19 AT AT00946165T patent/ATE270888T1/de not_active IP Right Cessation
- 2000-07-19 AU AU60039/00A patent/AU6003900A/en not_active Abandoned
- 2000-07-19 PT PT00946165T patent/PT1196170E/pt unknown
- 2000-07-19 WO PCT/GB2000/002788 patent/WO2001005385A2/en active IP Right Grant
- 2000-07-19 JP JP2001510442A patent/JP2003504396A/ja not_active Withdrawn
- 2000-07-19 CN CNB008105898A patent/CN1200710C/zh not_active Expired - Fee Related
- 2000-07-19 CA CA002379140A patent/CA2379140A1/en not_active Abandoned
- 2000-07-19 ES ES00946165T patent/ES2220492T3/es not_active Expired - Lifetime
- 2000-07-19 KR KR10-2002-7000291A patent/KR100508623B1/ko not_active IP Right Cessation
- 2000-07-19 DE DE2000612183 patent/DE60012183T2/de not_active Expired - Fee Related
-
2002
- 2002-12-24 HK HK02109332.6A patent/HK1047704B/zh not_active IP Right Cessation
-
2006
- 2006-04-18 US US11/405,679 patent/US20060287353A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN1361691A (zh) | 2002-07-31 |
| CA2379140A1 (en) | 2001-01-25 |
| HK1047704B (zh) | 2005-12-16 |
| JP2003504396A (ja) | 2003-02-04 |
| KR100508623B1 (ko) | 2005-08-17 |
| US20060287353A1 (en) | 2006-12-21 |
| ES2220492T3 (es) | 2004-12-16 |
| EP1196170B1 (en) | 2004-07-14 |
| DE60012183T2 (de) | 2004-11-18 |
| CN1200710C (zh) | 2005-05-11 |
| EP1196170A2 (en) | 2002-04-17 |
| GB9917158D0 (en) | 1999-09-22 |
| DE60012183D1 (de) | 2004-08-19 |
| WO2001005385A2 (en) | 2001-01-25 |
| AU6003900A (en) | 2001-02-05 |
| ATE270888T1 (de) | 2004-07-15 |
| PT1196170E (pt) | 2004-10-29 |
| WO2001005385A3 (en) | 2001-08-02 |
| KR20020060148A (ko) | 2002-07-16 |
| HK1047704A1 (en) | 2003-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60124256D1 (de) | Aspirin-ausgelöste lipidmediatoren | |
| CR8273A (es) | Administracion de ligandos de tlr7 y profarmacos de los mismos para el tratamiento de la infeccion por el virus de hepetitis c | |
| CY1121284T1 (el) | Θεραπεια ασθενειων που συνδυαζονται με τη χρηση αντιβιοτικων | |
| ATE277929T1 (de) | Immunsuppressive wirkungen von pteridinderivaten | |
| NO20052580D0 (no) | Blandinger for behandling av infeksjon av Flavivirida viruser | |
| WO2002080890A3 (en) | A jasmonate pharmaceutical composition for treatment of cancer | |
| PT1140139E (pt) | Utilizacao de eritropoietina ou derivados de eritropoietina para o tratamento de isquemia cerebral | |
| ATE534652T1 (de) | Phosphono-pent-2-en-1-yl-nukleoside und analoga | |
| ECSP045073A (es) | Nuevos derivados de piperazina | |
| DK1066056T3 (da) | Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernmangel, ... | |
| TNSN04100A1 (en) | Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof , the use thereof as medicaments, in addition to a medicament containing same | |
| AR007021A1 (es) | Derivados de 3-descladinosa-2,3-anhidroeritromicina, procedimientos para su preparacion, compuestos para su exclusivo uso en dichos procedimientosy procedimiento para su preparacion, una composicion farmaceutica para tratar infecciones bacterianas y el uso de estos compuestos para preparar medicamentos | |
| DK1150704T3 (da) | Melagatran til behandling af betændelse | |
| DK1196170T3 (da) | Anvendelse af en makrolidforbindelse til fremstilling af et medikament til behandling af hjerneskade forårsaget af iskæmi eller blödning | |
| BRPI0512732A (pt) | formulações tópicas para tratamento de doenças alérgicas | |
| PT1206444E (pt) | Compostos que inibem a actividade da triptase | |
| BRPI0414139A (pt) | métodos e composições para tratar infecções por herpes | |
| PA8531601A1 (es) | Nuevos heteroaromatos | |
| SE0200198D0 (sv) | New use | |
| DK1152760T3 (da) | Anvendelse af 4-aminopyridin til behandling af perifere neuropatier | |
| NO20021710D0 (no) | Anvendelse av 2-amino-3,4-dihydro-kinazoliner for fremstilling av et medikament for behandling eller profylakse avsykdommer bevirket av iskemiske tilstander | |
| BRPI0510906A (pt) | composição farmacêutica tópica, composição para administração tópica e seu uso | |
| DE602004022578D1 (de) | Antitumorale terpen-verbindungen | |
| DK1343523T3 (da) | Anvendelse af aktiveret faktor VII til behandling af thrombolytisk terapi-inducerede alvorlige blödninger | |
| BR0007395B1 (pt) | compostos de s-nitrosotióis como agentes para o tratamento de disfunções circulatórias. |